Upcoming Event - Pharma China Forum 1Q/2008
2/21/2008
Pharma China Forum
Feel the Pulse of China Pharma and Healthcare
Event: Pharma China Forum – 1st Quarter, 2008
Time: 2 PM to 4:30 PM, April 11, 2008
Introduction
Despite enormous business opportunities and growth prospects, the ever-changing legal, regulatory and market environments in China healthcare present the single biggest challenge to foreign pharmaceutical companies operating in the sector. Although there are success stories from all categories of players, becoming one of them requires a thorough understanding of the sector and its contemporary trends, knowledge to make informed decisions, flexibility to deal with changes, and capability to maneuver through complex situations. Failures to do so often lead to painful and costly mistakes, frustrations and even downfalls.
Since its inception in 2006, Pharma China, the leading English media covering China’s pharmaceutical sector, has been serving the mounting needs of the international business community in understanding the sector’s trends and developments as they unfold. The root of Pharma China as a reliable source of third party Chinese pharma intelligence can be traced back to IMS China Update, a joint monthly publication of IMS and WiCON (publisher of Pharma China).
In order to better serve our subscribers and meet the rising demand for in-depth understanding of contemporary issues and trends facing the Chinese pharmaceutical sector, Pharma China is convinced that a platform is needed to serve as a venue for exclusive information releases and expert observations by reputable industry sources, and for exchanges, peer discussions and brainstorming among experts and pharma executives whose working language is English.
This new platform to be launched in April is Pharma China Forum, a quarterly event to be held within two weeks after the end of each quarter. What set this event apart from those organized by professional conference companies are: 1) it is an event organized by executives for executives, 2) exclusive industry and market information contents are presented and distributed at the conference, 3) only the industry experts with real industry world experience to share are invited to present at the event, and 4) low cost – our goal is not profit but to bring value-added services to our subscribers and potential customers.
Each quarterly event of Pharma China Forum will feature a keynote presentation from James Shen, Publisher of Pharma China, on contemporary trends and developments in the previous quarter, followed by a presentation from another reputable information source, and one more presentation from an expert in a selected field of the pharmaceutical industry. The presentations are followed by interactive discussions and brainstorming between participants and an expert panel.
The upcoming Pharma China Forum on April 11 is sponsored by Synovate Healthcare China. Drawing from their three specialty China therapeutic monitors, experts from Synovate will report on the therapeutic and drug consumption trends in oncology, diabetes and hepatitis B areas. This event also features a presentation from Mark Lotter, CEO of Novamed Pharmaceuticals Inc. and a former Vice President Commercial Operations for AstraZeneca China. Mark will discuss the changing trends and landscape of hospital marketing and sales in China against a backdrop of many recent regulatory introductions and imminent healthcare reform. In addition, Dr. Songjun Luo, Principal ZS Associates (a leading sales force effectiveness consulting firm), will join us as a panelist.
CNY 1,000 - Non-subscribers of Pharma China
CNY 500 – Subscribers of any Pharma China products
Fee covers attendance, refreshments, copy of presentations, latest issue of Pharma China Journal Edition in print, and Pharma China Quarterly Review.
Invited Participants
Limited to mid- and senior level executives and competitive intelligence/market research related personnel of pharmaceutical companies, CROs and service providers serving international pharmaceutical companies, investment banking & consulting companies, and industry associations. The working language of participants should be English.
Registration
Spaces are limited to 30 participants and priority is given to Pharma China subscribers. Please contact:
David Xue
Tel: +86 10 8530-0937 Cell: +86 13911325130
Fax: +86 10 8530-0938 E-mail: dxue@pharmaguys.com
Agenda
|
|
Simple registration, refreshments, networking |
|
2:00 – 2:05 |
Opening and introduction of Pharma China and sponsor(s) |
|
2:00 – 2:50 |
James Shen, Publisher and Chief Editor, Pharma China
Review of Trends and Developments in the Chinese Pharmaceutical Industry in 1st Quarter, 2008
- Overview of the quarter
- Regulatory issues, events and trends
- Pharma industry trends, activities & performance data
- Legal/IPR – latest events and observations (if available)
- Healthcare reform/administration – trends and developments, newly available health statistics, etc. |
|
2:50 – 3:00 |
Break, exhibits and networking |
|
3:00 – 3:30 |
Rob Pollard, Director, Synovate Healthcare China
Kelly Price, Head of Asia Pacific Oncology Monitors, Synovate Healthcare
Patrick Nowlin, Director, Synovate Healthcare Shanghai
Therapeutic Trends in HepB, Oncology and Diabetes
- Overview
- Topline findings of Synovate’s China Hepatitis B Monitor
- Topline findings of Synovate’s China Diabetes Monitor
- Topline findings of Synovate’s China Oncology Monitor
- Future outlook |
|
3:30 – 4:00 |
Mark Lotter, CEO, Novamed Pharmaceuticals Inc. (former VP Commercial Operations, AstraZeneca China)
Changing Landscape: Sales and Marketing of Branded Ethical Drugs in Chinese Hospitals
- Review of latest trends and developments in this sector
- Regulations that have impacts on hospital sales and marketing
- Potential impacts of healthcare reform
- Future outlook |
|
4:00 – 4:30 |
Panel Discussion/Q&A: Contemporary Trends and Issues in China’s Pharma and Healthcare Sector
Panelists:
- James Shen, Publisher and Chief Editor, Pharma China
- Rob Pollard, Director, Synovate Healthcare China
- Kelly Price, Head of Asia Pacific Oncology Monitors, Synovate Healthcare
- Patrick Nowlin, Director, Synovate Healthcare Shanghai
- Mark Lotter, President & CEO, Novamed Pharmaceuticals
- Dr. Songjun Luo, Principal, ZS Associates Inc. (a leading SFE consulting firm) |
|
4:30 -5:00 |
Voluntary after-event Q&As, discussions, exhibits and networking |